2013 FDA/CMS Summit

Washington, USA
2013 FDA/CMS Summit
Elsevier Business Intelligence

Schedule of Presentations:

Wednesday, December 11, 2013
07:00:00 Registration and Continental Breakfast
08:00:00 Welcome and Opening Remarks Michael McCaughan
08:15:00 KEYNOTE ADDRESS: Priorities for FDA’s Drug Center in 2014 Janet Woodcock
09:00:00 FDA Roundtable John Jenkins, Gerald Dal Pan, Paul Seligman, Wendy Sanhai
10:30:00 Networking Break
11:00:00 Regulatory Gaps: What’s Left to “Fix” at FDA? Douglas C. Throckmorton, Gillian Woollett
12:15:00 Lunch
13:15:00 Health Reform in 2014: What to Expect After Jan. 1 Marc Samuels
14:30:00 Networking Break
14:45:00 Biosimilars in the US: What is Possible, and When? John Jenkins
16:00:00 Medicare Part D and Rx Regulation William Shrank, Cole Werble
17:00:00 Closing Keynote: Developing Successful Clinical, Regulatory and Patient Access Strategies in the Post Affordable Care Act Market
Thursday, December 12, 2013
08:30:00 Fireside Chat: Medicare in 2014 and Beyond Jonathan Blum, Michael McCaughan
09:15:00 Beyond the “Label”: Promotion in the Facebook Era Coleen Klasmeier, Adriane Fugh-Berman, Cole Werble
10:15:00 Networking Break
10:30:00 A Rare Opportunity: Orphan Drugs Gayatri Rao, Diane Dorman, Michael McCaughan
11:45:00 Networking Break and Working Box Lunch
12:00:00 Cancer Therapies: The Breakthrough Era Richard Pazdur, Victor Sandor
13:30:00 CMS Coverage Priorities Louis B. Jacques, Ramsey Baghdadi
14:30:00 Closing Keynote Margaret Hamburg
17:30:00 Registration and Continental Breakfast
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.